Mandragora and Umbilical erythema - from FDA reports


There is no Umbilical erythema reported by people who take Mandragora yet. This review analyzes which people have Umbilical erythema with Mandragora. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Mandragora and have Umbilical erythema, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Mandragora and have Umbilical erythema

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Jan, 17, 2018

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Umbilical erythema when taking Mandragora?

Expand the study to include all drugs with the same ingredients

Umbilical erythema and drugs with ingredients of european mandrake.

Expand the study to include reports from both FDA and eHealthMe

Umbilical erythema and Mandragora from FDA and eHealthMe reports


Mandragora has active ingredients of european mandrake. (latest outcomes from Mandragora 2 users)

Umbilical Erythema

Umbilical erythema (redness at umbilical site) has been reported by people with acute kidney failure, stenotrophomonas infection, respiratory tract infection, multiple sclerosis, diabetes (latest reports from 21 Umbilical erythema patients).

Browse all side effects of Mandragora

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Umbilical erythema

Umbilical erythema

Could your condition cause Umbilical erythema

Umbilical erythema

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Mandragora and have Umbilical erythema.